FDC Limited submitted its financial results for the quarter ended June 30, 2026, to the National Stock Exchange on August 5, 2026, following a board meeting held the same day. The announcement arrives months after the company declared an interim dividend of ₹5 per equity share at its February 5, 2026 board meeting, a payout that continues the company's sharply elevated dividend trend compared to its historical payouts.

Dividend Details and Recent History

The interim dividend of ₹5 per equity share declared in February 2026 matches the previous interim dividend of ₹5 per equity share declared on November 6, 2024. This consistency at the ₹5 level marks a significant step-up from the company's longer-term dividend history. The face value of each FDC equity share is Re. 1, making the ₹5 payout equivalent to a 500% dividend on face value.

Long-Term Dividend Trend

A review of FDC's dividend history over more than a decade reveals a clear upward trajectory in shareholder payouts:

The jump from ₹2.25 per share, which was the standard payout between 2013 and 2017, to ₹5.00 per share in the most recent cycles represents a 122% increase in per-share dividend quantum. The ₹0.80 interim payout in March 2020 was an outlier, likely reflecting the uncertainty at the onset of the COVID-19 pandemic.

Company Background

FDC Limited is a Mumbai-headquartered pharmaceutical company with operations spanning formulations and active pharmaceutical ingredients. The company's product portfolio includes brands across the oral rehydration, ophthalmic, and gastrointestinal therapeutic segments. FDC is listed on both NSE and BSE, with ISIN INE258B01022.

What the Q1 FY27 Results Submission Means for Investors

The submission of Q1 FY27 results, covering the April to June 2026 period, will provide investors with the first quarterly earnings data for the current financial year. Investors tracking FDC will look at revenue growth, EBITDA margins, and any guidance on future dividend payouts within the results disclosure. Given that the company has now declared two consecutive interim dividends at the ₹5 level, maintaining this quantum will be a key metric for income-oriented shareholders to monitor.

Note: Market price data, delivery percentage, 52-week range, and PE ratio figures were not available in the exchange filing at the time of publication. Dividend yield calculations and valuation comparisons will be updated upon availability of confirmed market data from NSE.